You Can Get Ozempic Online Without a Prescription. Is it Safe?
Holly Lofton, MD, director of the medical weight management program at NYU Langone Health, explains that GLP-1s and other similar medications can cost well over $1,000 per month without insurance. Dr. Lofton adds that many prescribers may not feel comfortable prescribing these medications ('They have not been properly trained or don't understand the complexity of overweight and obesity as chronic medical conditions,' she says), making it difficult for patients to get the drug from their primary care physicians.
These online platforms make it convenient for consumers looking to avoid having to go back and forth with their insurance and doctors, with a catch: They can be unregulated. 'This convergence of unmet demand and commercial supply has driven individuals toward alternative channels,' says Peter Goulden, MD, FRCP, division chief of the division of endocrinology, diabetes, and bone diseases at Mount Sinai. 'Often without full appreciation of the clinical risks involved.'
The Risks
Dr. Goulden says unregulated sources and the absence of clinical screenings of these drugs may lead to incorrect dosages, counterfeit products, or ineffective or contaminated products that can cause serious adverse effects such as dehydration, hypoglycaemia, and infection. You also risk not having access to regular monitoring with a licensed professional. Without a doctor or medical professional coaching you through long-term treatment, he says you risk possible negative interactions with medications you're already taking or worsening renal function, gallbladder disease, or pancreatitis. 'Circumventing the standard medical framework in favor of online acquisition undermines the safeguards designed to ensure appropriate, evidence-based use of these potent agents,' he says.
The Compound Issue
Compounded options also continue to grow in popularity online—causing great concern. Compounded medication, as Dr. Goulden explains it, is a drug that has been custom-made by a pharmacy onsite. It typically involves combining, mixing, or altering ingredients to meet the specific needs of a patient. It is only permitted when there is a genuine shortage of a commercial drug or when a patient has a specific need for it (e.g., an allergy to a preservative in the original medication) that the standard drug cannot provide.
When it comes to compounded Ozempic and other semaglutides, Dr. Goulden adds that they are not identical to their FDA-approved counterparts and are not subjected to the same rigorous testing or quality control. The FDA recently reported its concerns on fraudulent compounded GLP-1s in the market, where some don't even contain semaglutide at all.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
11 minutes ago
- Bloomberg
What If Everything We Think About Obesity Is Wrong?
The US government is approaching the study of obesity all wrong. According to leadership at the Department of Health and Human Services, food companies are to blame — they're engineering their snacks, fast food and sweets to addict us the same way cocaine and nicotine do. Others assessing the epidemic say people overeat because they lack willpower and could stop if they really wanted to.
Newsweek
2 hours ago
- Newsweek
Ohio Removes Over 600,000 People From Health Care Plan
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Hundreds of thousands of Americans in Ohio have been rolled off a health care plan in the space of roughly two years, data from KFF, a nonprofit health policy research and news organization, has shown. Around 600,000 Ohioans were disenrolled from the state's Medicaid program as part of the unwinding process happening nationwide after Medicaid coverage was expanded during the COVID pandemic. Newsweek has contacted the Ohio Department of Health via email for comment. Why It Matters The unwinding process has resulted in significant drops in Medicaid enrollment across the U.S. in recent years. Rates of decline in enrollment vary widely between states, with millions removed from the Medicaid program over two years in highly populated states, while other states have seen smaller, but still notable, decreases. Experts and policymakers both have warned how the growing number of Americans without health insurance will not only grow following the passage of President Donald Trump's budget bill, which will bring about major changes to the Medicaid program, but also how high uninsured rates will impact health outcomes and medical costs. File photo: three surgeons stand in an operating room with one making notes. File photo: three surgeons stand in an operating room with one making To Know In Ohio, there were 3,421,792 covered by Medicaid in March 2023, but by April 2025, that number was 2,802,277, KFF data shows. However, while this marked a drop of just over 600,000 Medicaid recipients, the enrollment levels had not returned back to prepandemic levels in April 2025, as they were still 8 percent higher than levels in February 2020—when there were 2,596,917 enrolled on the state's Medicaid program. These drops in Medicaid enrollment have been happening across the country after the COVID pandemic, when some states expanded the federal program under the Affordable Care Act (ACA). Federal rules forced states to keep recipients of the program enrolled, regardless of changes to eligibility, until March 2023. That month, states were then allowed to start an "unwinding process," where those no longer eligible for the program were disenrolled. However, concerns have been raised about the process with which recipients were pushed off the program in various states, with some experts saying that many individuals who were still eligible for the program were removed from it due to the administrative burden of proving eligibility. While some of those disenrolled from the Medicaid program in Ohio may have had access to other forms of health insurance, such as through employment, many may have been left uninsured. As Trump's budget bill will make significant cuts to the Medicaid program, as well as bringing in new work requirements among other changes, there is increasing concern about America's most vulnerable not having access to affordable health care - particularly in rural areas where many hospitals are also at risk of closure. What People Are Saying Bruce D. Meyer, a professor in the Harris School of Public Policy and the College at the University of Chicago, told Newsweek: "There will be financial difficulties for hospitals and clinics as uncompensated care increases. Based on the best research, financial hardship of low-income individuals will rise, as will their depression and other mental illnesses. Most starkly, mortality of adults is likely to rise in the states with large cutbacks in Medicaid coverage." What Happens Next As the unwinding continues, more reductions in enrollment are expected across the country, elevating concerns about how the rates of uninsured Americans could impact health outcomes.
Wall Street Journal
2 hours ago
- Wall Street Journal
The Race to Find a Measles Treatment as Infections Surge
As a record number of people in the U.S. are sickened with measles, researchers are resurrecting the search for something long-deemed redundant: treatments for the viral disease. After the measles vaccine was introduced in the 1960s, cases of the disease plummeted. By 2000, federal officials had declared measles eliminated from the U.S. This success led to little interest in the development of treatments. But now, as vaccination rates fall and infections rise, scientists are racing to develop drugs they say could prevent or treat the disease in vulnerable and unvaccinated people.
